Abstract
Nasal polyps (NPs) are benign lesions of nasal and paranasal sinuses mucosa affecting 1–4 % of all adults. Nasal polyposis affects the quality of patient’s life as it causes nasal obstruction, postnasal drainage, purulent nasal discharge, hyposmia or anosmia, chronic sinusitis, facial pain and snoring. Without treatment, the disease can alter the craniofacial skeleton in cases of extended growth of polyps. The development of NPs is caused by the hyperplasia of nasal or paranasal sinuses mucosa, and edema of extracellular matrix. This is usually the result of high concentration of high molecular mass hyaluronan (HA) which is either overproduced or accumulated from blood supply. The size of HA presents high diversity and, especially in pathologic conditions, chains of low molecular mass can be observed. In NPs, chains of about 200 kDa have been identified and considered to be responsible for the inflammation. The purpose of the present study was the investigation, in NPs and normal nasal mucosa (NM), of the expression of the wild-type and alternatively spliced forms of hyaluronidases, their immunolocalization, and the expression of HA synthases to examine the isoform(s) responsible for the increased amounts of HA in NPs. Hyaluronidases’ presence was examined on mRNA (RT-PCR analysis) and protein (immunohistochemistry) levels. Hyaluronan synthases’ presence was examined on mRNA levels. Hyaluronidases were localized in the cytoplasm of epithelial and inflammatory cells, as well as in the matrix. On mRNA level, it was found that hyal-1-wt was decreased in NPs compared to NM and hyal-1-v3, -v4 and -v5 were substantially increased. Moreover, HAS2 and HAS3 were the only hyaluronan synthases detected, the expression of which was almost similar in NPs and NM. Overall, the results of the present study support that hyaluronidases are the main enzymes responsible for the decreased size of hyaluronan observed in NPs; thus they behave as inflammatory agents. Therefore, they could be a potential target for the design of a more advanced treatment for nasal polyposis.
Similar content being viewed by others
Abbreviations
- NPs:
-
Nasal polyps
- CRS:
-
Chronic rhinosinusitis
- HA:
-
Hyaluronan
- HASs:
-
Hyaluronan synthases
- HYALs:
-
Hyaluronidases
- NM:
-
Nasal mucosa
References
Steinke JW, Payne SC, Chen PG, Negri J, Stelow EB, Borish L (2012) Etiology of nasal polyps in cystic fibrosis: not a unimodal disease. Ann Otol Rhinol Laryngol 121(9):579–586
Larsen K, Tos M (2002) The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol 122(2):179–182
Mygind N (1990) Nasal polyposis. J Allergy Clin Immunol 86(6 pt 1):827–829
Bernstein Joel M, Ballow Mark, Rich Gary, Allen Cheryl, Swanson Mia, Dmochowski Jacek (2004) Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp? Otolaryngol Head Neck Surg 130(5):526–535
Stammberger H (1999) Surgical treatment of nasal polyps: past, present, and future. Allergy 54(53):7–11
Hulse KE, Stevens WW, Tan BK, Schleimer RP (2015) Pathogenesis of nasal polyposis. Clin Exp Allergy 45(2):328–346
Laurent TC, Laurent UB, Fraser JR (1996) The structure and function of hyaluronan: an overview. Immunol Cell Biol 74:A1–A7
Heldin P, Karousou E, Bernert B, Porsch H, Nishitsuka K, Skandalis SS (2008) Importance of hyaluronan-CD44 interactions in inflammation and tumourigenesis. Connect Tissue Res 49:215–218
Pawlowska-Goral K, Gierek T, Majzel K, Wardas P, Wardas M (2005) Glycosoaminoglycans in nasal polyps. Acta Otolaryngol 125:177–179
Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–539
Stern R, Kogan G, Jedrzejas MJ, Soltes L (2007) The many ways to cleave hyaluronan. Biotechnol Adv 25:537–557
Lokeshwar VB, Schroeder GL, Carey RI, Soloway MS, Iida N (2002) Regulation of hyaluronidase activity by alternative mRNA splicing. J Biol Chem 277:33654–33663
Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85:699–715
Hatziri A, Vynios DH, Panogeorgou T, Bouga H, Triantaphylidou IE, Naxakis SS, Stathas T, Aletras AJ, Kourousis C, Mastronikolis NS (2013) Presence of hyaluronidase isoforms in nasal polyps. Eur Rev Med Pharmacol Sci 17:247–252
Rudack C, Prehm P, Stoll W, Maune S (2003) Extracellular matrix components in nasal polyposis. Acta Otolaryngol 123:643–647
Acknowledgments
The financial support of the Research Committee of the University of Patras is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest related to the present paper.
Rights and permissions
About this article
Cite this article
Panogeorgou, T., Tserbini, E., Filou, S. et al. Hyaluronan synthases and hyaluronidases in nasal polyps. Eur Arch Otorhinolaryngol 273, 1801–1808 (2016). https://doi.org/10.1007/s00405-015-3848-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-015-3848-6